Cooley
Megan Browdie
- Deals
- 10
- Latest
- Jun 2026
- Most deals in
- Biotech
Firm
- Cooley Law firm · 2026 · 10 deals
Often works with
- Paula Fleckenstein 4 deals together
- Todd Gluth 4 deals together
- Stephanie Gentile 4 deals together
- Karen Tsai 4 deals together
- Tony Guan 4 deals together
- Ross Eberly 3 deals together
- Ryan Montgomery 3 deals together
- Patrick Sharma 3 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jun 2026 | First Street | – | MSCI | Acquisition | Legal adviser to First Street (target) | Announced | 120.0 | Data & Analytics+1 | MSCI acquisition of First Street |
| Jun 2026 | GPTZero | – | Superhuman | Acquisition | Legal adviser to GPTZero (target) | Announced | – | AI | Superhuman acquisition of GPTZero |
| May 2026 | Vaccine Company | – | Lilly | Acquisition | Legal adviser to Vaccine Company (target) | Announced | 1,550.0 | Biotech+1 | Lilly acquisition of Vaccine Company |
| May 2026 | Engage Bio | – | Eli Lilly | Acquisition | Legal adviser to Engage Bio (target) | Announced | 202.0 | Biotech+1 | Eli Lilly acquisition of Engage Bio |
| May 2026 | Peloton Consulting Group | – | Sunstone Partners | Stake | Legal adviser to Peloton Consulting Group (target) | Announced | – | IT Services+1 | Sunstone Partners stake in Peloton Consulting Group |
| Apr 2026 | Ajax Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Ajax Therapeutics (target) | Announced | 2,300.0 | Biotech+2 | Eli Lilly and Company acquisition of Ajax Therapeutics |
| Mar 2026 | PFF enterprise (B2B) business | Pro Football Focus | Teamworks | Asset sale | Legal adviser to Pro Football Focus (seller) | Announced | – | Data & Analytics | Teamworks acquisition of PFF enterprise (B2B) business |
| Mar 2026 | Rivian Automotive | – | Uber Technologies | Stake | Legal adviser to Uber Technologies (acquirer) | Announced | 300.0 | Automotive+1 | Uber Technologies stake in Rivian Automotive |
| Feb 2026 | 35Pharma | – | GSK | Acquisition | Legal adviser to 35Pharma (target) | Announced | 950.0 | Biotech+1 | GSK acquisition of 35Pharma |
| Feb 2026 | Veros Technologies | Razor's Edge | Quantum Leap | Acquisition | Legal adviser to Veros Technologies (target) | Completed | – | Cybersecurity+2 | Quantum Leap acquisition of Veros Technologies |
Deals where Megan Browdie is named on the firm's deal team, by the firm or the press.